persistent lingering cough; Did not feel well after receiving the first vaccine dose; Diarrhea; sweating at night; Congestion; Coughing bloody film; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Did not feel well after receiving the first vaccine dose), DIARRHOEA (Diarrhea), NIGHT SWEATS (sweating at night), NASAL CONGESTION (Congestion) and HAEMOPTYSIS (Coughing bloody film) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in October 2020.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced MALAISE (Did not feel well after receiving the first vaccine dose), DIARRHOEA (Diarrhea), NIGHT SWEATS (sweating at night), NASAL CONGESTION (Congestion) and HAEMOPTYSIS (Coughing bloody film). On an unknown date, the patient experienced COUGH (persistent lingering cough). At the time of the report, MALAISE (Did not feel well after receiving the first vaccine dose), DIARRHOEA (Diarrhea), NIGHT SWEATS (sweating at night), NASAL CONGESTION (Congestion) and HAEMOPTYSIS (Coughing bloody film) had resolved and COUGH (persistent lingering cough) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided.    This case was linked to MOD-2021-076309 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Event added and event outcomes updated. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 14-Apr-2021 and was forwarded to Moderna on 14-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Did not feel well after receiving the first vaccine dose), DIARRHOEA (Diarrhea), NIGHT SWEATS (sweating at night), NASAL CONGESTION (Congestion) and HAEMOPTYSIS (Coughing bloody film) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in October 2020.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced MALAISE (Did not feel well after receiving the first vaccine dose), DIARRHOEA (Diarrhea), NIGHT SWEATS (sweating at night), NASAL CONGESTION (Congestion) and HAEMOPTYSIS (Coughing bloody film). On an unknown date, the patient experienced COUGH (persistent lingering cough). At the time of the report, MALAISE (Did not feel well after receiving the first vaccine dose), DIARRHOEA (Diarrhea), NIGHT SWEATS (sweating at night), NASAL CONGESTION (Congestion) and HAEMOPTYSIS (Coughing bloody film) had resolved and COUGH (persistent lingering cough) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided.    This case was linked to MOD-2021-076309 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Event added and event outcomes updated.